Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration’ [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] (Seminars in Arthritis and Rheumatism (2022) 56, (S0049017222001329), (10.1016/j.semarthrit.2022.152081))

Simple item page
dc.contributor.authorØrnbjerg L.M.
dc.contributor.authorLinde L.
dc.contributor.authorGeorgiadis S.
dc.contributor.authorRasmussen S.H.
dc.contributor.authorLindström U.
dc.contributor.authorAskling J.
dc.contributor.authorMichelsen B.
dc.contributor.authorGiuseppe D.D.
dc.contributor.authorWallman J.K.
dc.contributor.authorPavelka K.
dc.contributor.authorZávada J.
dc.contributor.authorNissen M.J.
dc.contributor.authorJones G.T.
dc.contributor.authorRelas H.
dc.contributor.authorPirilä L.
dc.contributor.authorTomšič M.
dc.contributor.authorRotar Z.
dc.contributor.authorGeirsson A.J.
dc.contributor.authorGudbjornsson B.
dc.contributor.authorKristianslund E.K.
dc.contributor.authorvan der Horst-Bruinsma I.
dc.contributor.authorLoft A.G.
dc.contributor.authorLaas K.
dc.contributor.authorIannone F.
dc.contributor.authorCorrado A.
dc.contributor.authorCiurea A.
dc.contributor.authorSantos M.J.
dc.contributor.authorSantos H.
dc.contributor.authorCodreanu C.
dc.contributor.authorAkkoc N.
dc.contributor.authorGunduz O.S.
dc.contributor.authorGlintborg B.
dc.contributor.authorØstergaard M.
dc.contributor.authorHetland M.L.
dc.date.accessioned2024-07-22T08:03:06Z
dc.date.available2024-07-22T08:03:06Z
dc.date.issued2023
dc.description.abstractThe authors regret that the following incorrect values have been published in the original paper: In the abstract: Line 11-12: “age, per year: 0.97 (0.97-0.98)” should be “age, per year: 0.98 (0.97-0.99)” Line 12: “men vs. women: 1.88 (1.60-2.22)” should be “men vs. women: 1.79 (1.51-2.12)” Line 12: “current vs. non-smoking: 0.76 (0.63-0.91)” should be “current vs. non-smoking: 0.72 (0.59-0.87)” Line 12-13: “HLA-B27 positive vs. negative: 1.51 (1.20-1.91)” should be “HLA-B27 positive vs. negative: 1.65 (1.27-2.15)” Line 14: “CRP>10 vs. ≤10 mg/l: 1.49 (1.25-1.77)” should be “CRP>10 vs. ≤10 mg/l: 1.36 (1.14-1.62)” Line 15-16: “fatigue and spinal pain: 0.99 (0.99-1.00) and 0.99 (0.99-1.99)” should be “fatigue and spinal pain: 0.99 (0.99-0.99) and 0.99 (0.99-1.00)” In Table 3, row with EPV (row 3 after header/subheader): Column with header/subheader “Czech Republic/ATTRA”: EPV 15.9 should be 13.2 Column with header/subheader “Netherlands/ARC”: EPV 1 should be 1.0 Column with header/subheader “Portugal/Reuma.pt”: EPV 14.7 should be 13.1 Column with header/subheader “Romania/RRBR”: EPV 2.8 should be 2.4 Column with header/subheader “Turkey/TURKBIO”: EPV 12.9 should be 11.8 In Table 5, row with “Patient global score, mm” (row 10 counting from row with “Age at treatment start, years”): In the column with header: “Analysis of 12-month drug retention” and subheader: “Univariate”, the value for the odds ratio (OR) is missing. The OR should be 0.99. The authors would like to apologise for any inconvenience caused. © 2022 The Authors
dc.identifier.DOI-ID10.1016/j.semarthrit.2022.152141
dc.identifier.issn00490172
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/12128
dc.language.isoEnglish
dc.publisherW.B. Saunders
dc.rightsAll Open Access; Green Open Access
dc.subjecterratum
dc.titleCorrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration’ [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] (Seminars in Arthritis and Rheumatism (2022) 56, (S0049017222001329), (10.1016/j.semarthrit.2022.152081))
dc.typeErratum

Files

Collections

Scopus Koleksiyonu